Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-112.56%Return on Equity
VS
Market
Sector
Industry
History
$ 25.38Close
$ 10 - $ 29.6 52-Week Range
Ticker Information
Ticker
CLPTCompany Name
CLEARPOINT NEURO INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQCLEARPOINT NEURO INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CLPT - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 19.74M | $ -22.22M | -112.56% |
| 3/31/2025 | $ 19.99M | $ -20.79M | -104.04% |
| 12/31/2024 | $ 25.39M | $ -18.91M | -74.5% |
| 9/30/2024 | $ 29M | $ -18.15M | -62.57% |
| 6/30/2024 | $ 32.13M | $ -17.98M | -55.96% |
| 3/31/2024 | $ 34.58M | $ -20.63M | -59.64% |
| 12/31/2023 | $ 21.17M | $ -22.09M | -104.33% |
| 9/30/2023 | $ 24.09M | $ -21.86M | -90.71% |
| 6/30/2023 | $ 27.41M | $ -20.83M | -76.01% |
| 3/31/2023 | $ 32.58M | $ -18.09M | -55.51% |
Key Performance Insights, Last 5 Years
- CLEARPOINT NEURO INC's latest trailing twelve months (TTM) ROE stands at -4591.42%.
- Over the past 5 years, CLEARPOINT NEURO INC's average ROE has been -296.15%.
- The median ROE for CLEARPOINT NEURO INC during this period was -57.8%
- CLEARPOINT NEURO INC reached its highest ROE over the past 5 years at -16.52%.
- The lowest ROE recorded by CLEARPOINT NEURO INC in the same timeframe -4591.42%
CLEARPOINT NEURO INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for CLEARPOINT NEURO INC is calculated as follows: Net Inc. Cmn. [ $ -6.85M ] / Equity [ $ 149.1K ]
(=) ROE [ -4591.42% ] CLPT - Return on Equity, Last 5 years
-4591.42%
Minimum
Sep 30, 2020
-16.52%
Maximum
Mar 31, 2021
-296.15%
Average
-57.8%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |